← Open Payments lookup

KATIE URAM: Open Payments

NPI 1396023099 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$827 in 49 payments from 16 companies in 2025. Trend: 2023 $648 · 2024 $581 · 2025 $827

Food & beverage: $827
CompanyPaymentsAmount
Novo Nordisk Inc14$175
PFIZER INC.10$166
Lundbeck LLC3$84
GlaxoSmithKline, LLC.3$64
ABBVIE INC.3$62
Boehringer Ingelheim Pharmaceuticals, Inc.3$57
Merck Sharp & Dohme LLC2$38
Lilly USA, LLC2$30
Esperion Therapeutics, Inc.2$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26

Products named: REXULTI, NURTEC ODT, TRELEGY ELLIPTA, JARDIANCE, Ozempic, PREVNAR 20, VRAYLAR, ELIQUIS.

Industry payments across PA — which companies pay providers there.